Orphan Drug Forum: Regulatory, Compliance, and Business Issues in Rare Diseases

Overview

The FDLI Orphan Drug Forum in Boston, MA is a one-day educational conference designed specifically for the biotechnology community. This forum provides a comprehensive examination of the legal, regulatory, compliance, and commercialization issues unique to orphan drugs and rare disease therapies.

The program brings together industry leaders, FDA and former FDA officials, patient advocacy organizations, legal and compliance professionals, investors, and biotechnology innovators to discuss the evolving landscape of rare disease product development from early clinical research through commercialization.

Register

Registration Open Soon

Premier